Clinical Trial Update: Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dasatinib with gemcitabine hydrochloride or gemcitabine alone in previously surgically treated pancreatic cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• DASATINIB (Dasatinib)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)

Snippet

Sponsor: Translational Oncology Research International | Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas | Phase 2 | Status: COMPLETED